The Latest Cardiac and Vascular News
Newly Assigned Rates Further Validate Commercial Value of the HART Tests KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., The AI-Powered Cardiac Blood Test Company, today announced the Centers for Medicare & Medicaid Services (CMS) has set a National Medicare payment rate of $390.75 for […]
Receipt of dedicated CPT® codes mark important commercialization milestone to pursue reimbursement for Prevencio’s multi-protein HART CADhs®, HART CVE®, and HART KD® Blood Tests KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., The AI-driven Cardiac Company™, today announces that the American Medical Association (AMA) has assigned […]
